GET DAILY SIGNALSFirst Trust Consumer Staples AlphaDEX Fund (FXG) Eyes +14% Upside to $71
Key Takeaways
- The First Trust Consumer Staples AlphaDEX Fund (FXG) is an ETF, not a single stock, so its "price target" is derived from public market discussion rather than a direct analyst consensus on the fund itself.
- A widely cited objective of roughly $71 (rounded from a TipRanks aggregate figure near $71.29) reflects the average analyst price target across the roughly 40-plus stocks the fund holds, with that aggregate ranging from about $62 to $83.
- With FXG trading near $62, reaching $71 would require an upside of about 14%, a substantial move for a low-beta consumer staples fund.
- Supporting factors include defensive demand, falling-rate sensitivity, and diversified, factor-weighted exposure to staples, food, and healthcare distribution names.
- Key risks include concentrated top holdings, a higher expense ratio, cyclical food and commodity-linked positions, and valuation pressure if staples rotate out of favor.
- Readers can dig deeper into FXG's Major News, Today's Price Move, Forecast, and Earnings on dedicated pages.
- For AI-driven market monitoring, explore Trending AI Robots to follow automated trading ideas across stocks and ETFs.
How the Target Was Established
The First Trust Consumer Staples AlphaDEX Fund (FXG) is a passively managed ETF that tracks the StrataQuant Consumer Staples Index, a modified equal-dollar-weighted index that screens large- and mid-cap U.S. consumer staples stocks from the Russell 1000 using the AlphaDEX methodology. Because ETFs are baskets of holdings, Wall Street does not assign FXG a standalone analyst price target in the same way it does for individual equities.
Instead, the $71 objective comes from public market discussion of the fund's underlying holdings. Research platforms that aggregate the 12-month analyst price targets of FXG's roughly 40-plus positions arrive at an average figure near $71.29, with individual holding-level forecasts spanning roughly $62 to $83. Rounded for readability, that yields a central target of about $71. This is a derived, holdings-based objective, not an official consensus on the ETF itself, and it should be read as context rather than a guaranteed destination. I also checked comparable names using Tickeron’s AI Screener to see how the holdings stack up.
Current Market Position and Path Toward the Target
FXG has traded recently around $62, within a 52-week range of roughly $57 to $70. Reaching $71 would require an increase of about 14%, a substantial move for a fund whose five-year beta sits near 0.5 and that has historically delivered low-to-mid single-digit annualized returns alongside a dividend yield of roughly 2% to 2.5%.
The fund carries an expense ratio of about 0.63%, relatively high compared with broad staples rivals, and manages a modest asset base of roughly $230 million to $250 million. Its largest positions span food and agriculture names such as Bunge, Pilgrim's Pride, Smithfield Foods, and Ingredion, alongside healthcare distributors McKesson and Cencora and retailers like Casey's General Stores. This tilts the fund toward defensive consumer demand and distribution, but also leaves it exposed to commodity prices and food-industry cyclicality.
What Could Support a Move Toward the Target
Several factors could underpin a grind higher. Consumer staples tend to hold up when economic uncertainty rises, and any shift by the FOMC toward lower interest rates historically supports defensive, dividend-paying equity segments. Solid fundamentals among top holdings, including resilient grocery and pharmaceutical distribution businesses, provide a stable earnings base. Because the fund is equal-dollar-weighted, it avoids the mega-cap concentration of cap-weighted staples funds, allowing mid-cap names to contribute more meaningfully to performance. The aggregate analyst targets on holdings, which skew toward "buy" and "hold," suggest underlying companies are expected to grow earnings, supporting a higher market outlook.
What Could Prevent the Target From Being Reached
The main obstacles are structural and valuation-driven. A 14% move is demanding for a low-beta fund, and FXG has already approached the upper end of its recent trading range without sustaining a breakout. Its 0.63% expense ratio creates a persistent drag relative to lower-cost staples ETFs. Exposure to food, agriculture, and commodity-linked names introduces earnings volatility that pure-brand staples funds avoid, and a reversal in the defensive rotation — or a reacceleration in growth stocks — could leave staples lagging. Finally, because the $71 figure is an average of holdings' targets, weak results or downward revisions at just a few large positions could pull the aggregate objective lower.
Technical Levels and Market Structure
FXG's 52-week high near $70 acts as the nearest major resistance, with the $71 objective sitting just above it, making that zone a meaningful psychological and technical barrier. On the downside, support has repeatedly formed in the upper $50s to low $60s, and long-term moving averages have clustered around the low-to-mid $60s. A decisive close above $70 would mark a breakout to new highs, while failure at that level could keep the fund range-bound between roughly $57 and $70.
Time Horizon and What Investors Should Monitor
The holdings-based targets underlying the $71 figure generally reflect a roughly 12-month research horizon, though individual analysts differ. Investors should watch quarterly earnings from the fund's largest positions, particularly Bunge, McKesson, Cencora, and Casey's General Stores, along with food-commodity prices, consumer-spending data, and FOMC rate decisions. Changes to the fund's holdings weighting, expense structure, or sector allocation, and any notable inflows or outflows from the staples category, are also worth tracking. From what I see, these elements will shape whether the derived target holds.
AI Daily Buy/Sell Signals
I have been using Tickeron’s AI Daily Buy/Sell Signals to monitor FXG and the broader staples space. These signals apply artificial intelligence to track thousands of stocks and ETFs in real time, delivering Buy, Sell, or Hold alerts as technical conditions and market data evolve. They help surface short-term shifts without requiring constant manual review, which I find useful when following sector rotation or individual holdings.
Final Assessment
The question of whether the First Trust Consumer Staples AlphaDEX Fund can reach $71 ultimately hinges on a roughly 14% advance — a substantial move for this low-beta ETF. The objective derives from the average analyst price target on the fund's underlying holdings, not a direct consensus on FXG itself, and the wide underlying range of about $62 to $83 shows meaningful disagreement. Defensive demand, potential rate cuts, and a diversified factor-weighted portfolio provide support, while the high fee, commodity-linked holdings, and resistance near $70 present real obstacles. Investors should monitor holdings earnings, commodity prices, and rate policy rather than treat $71 as an assured destination.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
FXG in upward trend: 10-day moving average broke above 50-day moving average on October 28, 2026
The 10-day moving average for FXG crossed bullishly above the 50-day moving average on October 28, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 18 of 19 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 90%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where FXG's RSI Indicator exited the oversold zone, 19 of 23 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 83%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 48 of 55 cases where FXG's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 87%.
The Momentum Indicator moved above the 0 level on November 02, 2026. You may want to consider a long position or call options on FXG as a result. In 80 of 95 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 84%.
The Moving Average Convergence Divergence (MACD) for FXG just turned positive on October 06, 2026. Looking at past instances where FXG's MACD turned positive, the stock continued to rise in 39 of 47 cases over the following month. The odds of a continued upward trend are 83%.
FXG moved above its 50-day moving average on October 30, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +3.05% 3-day Advance, the price is estimated to grow further. Considering data from situations where FXG advanced for three days, in 258 of 316 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.
The Aroon Indicator entered an Uptrend today. In 181 of 273 cases where FXG Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 66%.
Bearish Trend Analysis
The 50-day moving average for FXG moved below the 200-day moving average on October 05, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where FXG declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 77%.
FXG broke above its upper Bollinger Band on October 14, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
Category ConsumerStaples
Advertisement